Apimeds Pharmaceuticals US Balance Sheet (2023-2025) | APUS

Balance Sheet Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter) 0.41M0.00M0.25M8.74M6.99M1.64M
Short-term Investments (Quarter) 2.00M
Cash & Current Investments (Quarter) 0.41M0.00M0.25M8.74M6.99M3.64M
Prepaid Assets (Quarter) 0.01M0.01M0.01M1.61M0.34M0.05M
Current Assets (Quarter) 0.42M0.01M0.26M10.35M9.09M13.98M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 0.01M0.03M0.05M
Other Non-Current Assets (Quarter) 0.18M0.13M0.08M
Non-Current Assets (Quarter) 0.20M0.16M150.20M
Assets (Quarter) 0.42M0.01M0.26M10.55M9.25M164.18M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 0.05M0.59M0.94M0.12M0.57M0.92M
Notes Payables (Quarter) 0.27M0.25M0.37M7.09M
Payables (Quarter) 0.32M0.84M1.31M0.12M0.57M8.01M
Accumulated Expenses (Quarter) 0.50M
Other Accumulated Expenses (Quarter) 0.08M0.09M100.00100.00
Short term Debt (Quarter) 1.62M
Current Leases (Quarter) 0.04M
Total Current Liabilities (Quarter) 0.12M1.02M1.77M0.81M1.09M10.71M
Non-Current Liabilities
Non-Current Debt (Quarter) 0.25M
Convertible Debt (Quarter) 0.35M0.15M0.15M
Operating Leases (Quarter) 0.13M
Other Non-Current Liabilities (Quarter) 0.07M0.17M1.62M
Total Non-Current Liabilities (Quarter) 0.32M0.63M9.22M
Total Liabilities (Quarter) 0.39M0.26M0.71M1.05M1.37M2.02M0.81M1.09M10.84M
Shareholder's Equity
Total Debt (Quarter) 0.25M1.62M
Common Equity (Quarter) 0.03M-0.26M-0.71M-1.05M-1.36M-1.76M9.74M8.16M153.35M
Shareholder's Equity (Quarter) 0.03M-0.26M-0.71M-1.05M-1.36M-1.76M9.74M8.16M153.35M
Liabilities and Shareholders Equity (Quarter) 0.42M0.01M0.26M10.55M9.25M164.18M
Retained Earnings (Quarter) -3.00M-4.39M-4.79M-7.46M-9.24M-10.39M
Preferred Shares (Quarter) 0.07M